B., Hollingsworth, J
Real talk: the research on topical glutathione for skin lightening is still evolving
Finally, the applicant highlighted that, while the study is ongoing and data remains subject to final investigator approval and statistical analysis, preliminary, 100 percent source-verified observations to date are consistent with the FDA-cleared intended use and function of the Axoguard HA+ Nerve Protector TM
Fang Wang, Hunan Agricultural University, China Updates Copyright 2023 Hou, Michiels, Kerschaver, Vandaele, Majdeddin, Vossen and Degroote
This study was approved by the ethics committee of Hamadan University of Medical Sciences with IR.UMSHA.REC.1399.650 ethics code and registered in the Iranian Registry of Clinical Trials (IRCT20200921048794N1)
The facility also notes that "rapid and irregular changes in mole appearance" may occur